Breaking News Instant updates and real-time market news.

AVEO

Aveo Pharmaceuticals

$2.00

0.005 (0.25%)

07:03
11/09/18
11/09
07:03
11/09/18
07:03

Aveo Pharmaceuticals reports Q3 EPS (18c), consensus (6c)

Reports Q3 revenue $2.5M, may not compare to consensus $680,000.

  • 27

    Nov

AVEO Aveo Pharmaceuticals
$2.00

0.005 (0.25%)

10/22/18
PIPR
10/22/18
NO CHANGE
Target $5
PIPR
Overweight
TiNivo data competitively position Aveo Pharmaceuticals, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff believes the data for tivozanib combined with Opdivo to treat metastatic renal cell carcinoma presented at the ESMO meeting competitively position Aveo Pharmaceuticals as the treatment landscape for front-line RCC moves to I-O and TKI combinations. An ORR of 56% and DCR of 96% represent "promising early activity," said Tenthoff., who reiterates his Overweight rating and $5 target on Aveo shares.
11/05/18
PIPR
11/05/18
NO CHANGE
Target $5
PIPR
Overweight
Aveo Pharmaceuticals tivozanib's initial sales seen at $27M, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff kept his Overweight rating and $5 price target on Aveo Pharmaceuticals after its announcement this evening that the phase 3 TIVO-3 trial of tivozanib vs. Nexavar in 3rd line renal cell carcinoma met its primary endpoint target. The analyst expects the company to file a New Drug Application for tivozanib in the next 6 months, and after its expected approval, he estimates that the initial 2020 sales will be around $27M before reaching about $189M in 2025. Tenthoff adds that based on the data, there is further opportunity for tivozanib use in compbination with Opdivo.
11/06/18
HCWC
11/06/18
NO CHANGE
Target $9
HCWC
Buy
Aveo Pharmaceuticals price target raised to $9 from $6.50 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Aveo Pharmaceuticals to $9 saying the company announced positive topline results from the Phase 3 TIVO-3 study investigating the use of tivozanib for the treatment of refractory renal cell carcinoma. The analyst views the results as "very promising" and believes tivozanib still has "ample opportunity" to show a superior overall survival benefit. He believes the drug is on track for approval in 2020 and keeps a Buy rating on Aveo Pharmaceuticals.
11/06/18
NATL
11/06/18
DOWNGRADE
NATL
Neutral
Aveo Pharmaceuticals downgraded to Neutral from Buy at National Securities

TODAY'S FREE FLY STORIES

13:23
03/19/19
03/19
13:23
03/19/19
13:23
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

GOOG

Alphabet

$1,190.42

6.76 (0.57%)

, GOOGL

Alphabet Class A

$1,194.51

6.42 (0.54%)

13:20
03/19/19
03/19
13:20
03/19/19
13:20
Hot Stocks
Google says Stadia to include button on YouTube gaming videos to play instantly »

Google (GOOG) says Stadia…

GOOG

Alphabet

$1,190.42

6.76 (0.57%)

GOOGL

Alphabet Class A

$1,194.51

6.42 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

GOOG

Alphabet

$1,190.00

6.34 (0.54%)

, GOOGL

Alphabet Class A

$1,194.10

6.01 (0.51%)

13:17
03/19/19
03/19
13:17
03/19/19
13:17
Hot Stocks
Google announces game streaming service Stadia »

Google's (GOOG) Phil…

GOOG

Alphabet

$1,190.00

6.34 (0.54%)

GOOGL

Alphabet Class A

$1,194.10

6.01 (0.51%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
03/19/19
03/19
13:17
03/19/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
03/19/19
03/19
13:16
03/19/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,188.47

4.81 (0.41%)

, GOOGL

Alphabet Class A

$1,191.43

3.34 (0.28%)

13:10
03/19/19
03/19
13:10
03/19/19
13:10
Hot Stocks
Google CEO says aiming to build a game platform 'for everyone' »

Google (GOOG) CEO Sundar…

GOOG

Alphabet

$1,188.47

4.81 (0.41%)

GOOGL

Alphabet Class A

$1,191.43

3.34 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

NOG

Northern Oil and Gas

$2.47

0.01 (0.41%)

13:10
03/19/19
03/19
13:10
03/19/19
13:10
Options
Notable spread in Northern Oil and Gas »

Notable spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$282.92

0.46 (0.16%)

13:08
03/19/19
03/19
13:08
03/19/19
13:08
Periodicals
U.S., China trade talks in final stages, WSJ reports »

The trade talks between…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$282.92

0.46 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$33.10

-0.01 (-0.03%)

13:05
03/19/19
03/19
13:05
03/19/19
13:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
03/19/19
03/19
13:05
03/19/19
13:05
General news
Treasury Action: trade worries are putting a bid in Treasuries »

Treasury Action: trade…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.29

0.83 (0.29%)

13:03
03/19/19
03/19
13:03
03/19/19
13:03
Periodicals
Markets drop after Bloomberg report on China walking back some trade offers 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.29

0.83 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$57.42

1.01 (1.79%)

12:55
03/19/19
03/19
12:55
03/19/19
12:55
Options
Williams Sonoma put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

ZNGA

Zynga

$5.37

0.02 (0.37%)

, AMZN

Amazon.com

$1,782.25

40.25 (2.31%)

12:52
03/19/19
03/19
12:52
03/19/19
12:52
Periodicals
Amazon focuses on building game industry's digital infrastructure, Variety says »

Amazon (AMZN), which owns…

ZNGA

Zynga

$5.37

0.02 (0.37%)

AMZN

Amazon.com

$1,782.25

40.25 (2.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

SPY

SPDR S&P 500 ETF Trust

$283.90

1.44 (0.51%)

, SPX

S&P 500

$0.00

(0.00%)

12:50
03/19/19
03/19
12:50
03/19/19
12:50
Periodicals
Some U.S. officials see China walking back trade offers, Bloomberg reports »

Some U.S. officials are…

SPY

SPDR S&P 500 ETF Trust

$283.90

1.44 (0.51%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$284.09

1.63 (0.58%)

, SPX

S&P 500

$0.00

(0.00%)

12:47
03/19/19
03/19
12:47
03/19/19
12:47
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Some U.S. officials see…

SPY

SPDR S&P 500 ETF Trust

$284.09

1.63 (0.58%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$6.70

0.27 (4.20%)

12:45
03/19/19
03/19
12:45
03/19/19
12:45
Options
SunPower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$201.50

-4.35 (-2.11%)

12:35
03/19/19
03/19
12:35
03/19/19
12:35
Options
Shopify put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$76.60

-1.23 (-1.58%)

12:32
03/19/19
03/19
12:32
03/19/19
12:32
Hot Stocks
Iberiabank board of directors raises quarterly dividend 5% to 43c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

, MSFT

Microsoft

$117.78

0.18 (0.15%)

12:26
03/19/19
03/19
12:26
03/19/19
12:26
On The Fly
Game On: An exclusive talk with The Voxel Agents' Simon Joslin »

'GARDENS BETWEEN': In an…

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$117.78

0.18 (0.15%)

SNE

Sony

$46.20

0.105 (0.23%)

FB

Facebook

$163.32

2.86 (1.78%)

TCEHY

Tencent

$0.00

(0.00%)

ATVI

Activision Blizzard

$46.95

1.98 (4.40%)

TTWO

Take-Two

$96.16

2.4 (2.56%)

EA

Electronic Arts

$98.79

-0.9 (-0.90%)

UBSFY

Ubisoft

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

PBR

Petrobras

$17.49

0.38 (2.22%)

12:25
03/19/19
03/19
12:25
03/19/19
12:25
Options
Petrobras call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,194.39

10.73 (0.91%)

, GOOGL

Alphabet Class A

$1,198.03

9.94 (0.84%)

12:21
03/19/19
03/19
12:21
03/19/19
12:21
Periodicals
'Cheaper' Google Pixel may be coming, Mashable says »

Citing prior reports…

GOOG

Alphabet

$1,194.39

10.73 (0.91%)

GOOGL

Alphabet Class A

$1,198.03

9.94 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

CPRX

Catalyst Pharmaceuticals

$3.40

0.31 (10.03%)

12:21
03/19/19
03/19
12:21
03/19/19
12:21
Recommendations
Catalyst Pharmaceuticals analyst commentary  »

Catalyst comments point…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

NVDA

Nvidia

$175.42

6.51 (3.85%)

12:20
03/19/19
03/19
12:20
03/19/19
12:20
Hot Stocks
Nvidia up 4% as executives present at investor day meeting »

Nvidia said during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

BRQS

Borqs Technologies

$4.22

(0.00%)

12:20
03/19/19
03/19
12:20
03/19/19
12:20
Hot Stocks
Breaking Hot Stocks news story on Borqs Technologies »

Borqs Technologies Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
03/19/19
03/19
12:17
03/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.